OncoSwab

🗓 Founded 2023👥 7 employees💰 Last funded Aug 2024
Biotechnology Research🌐 oncoswab.com
Website LinkedIn
75% of lung cancer cases are detected too late. OncoSwab is changing that. Our mission: make early detection accessible with a non-invasive, easy-to-use test. Founded by visionary scientists and supported by the Health Wildcatters Accelerator, Swiss Governments DayOne Tech, and several pre-seed investors, OncoSwab is currently conducting a proof-of-concept trial with the collaboration of top US and European hospitals and lung cancer experts, aiming to save lives worldwide. OncoSwab has offices in San Francisco, California and Corroux, Switzerland.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in OncoSwab?
OncoSwab has 1 investors on record on gritt.io, including 1 early-stage backers.
When did OncoSwab last raise funding?
The most recent investment in OncoSwab recorded on gritt.io was in August 2024.
When was OncoSwab founded?
OncoSwab was founded in 2023.
What industry is OncoSwab in?
OncoSwab operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.